EMRELIS Trademark

Trademark Overview


On Wednesday, April 1, 2015, a trademark application was filed for EMRELIS with the United States Patent and Trademark Office. The USPTO has given the EMRELIS trademark a serial number of 86583898. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 26, 2021. This trademark is owned by Actavis, Inc.. The EMRELIS trademark is filed in the Pharmaceutical Products category with the following description:

Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting the sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceutica...
emrelis

General Information


Serial Number86583898
Word MarkEMRELIS
Filing DateWednesday, April 1, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 26, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 23, 2018

Trademark Statements


Goods and ServicesOral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting the sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting the urogenital organs; Pharmaceuticals and medicines affecting the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 10, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameALLERGAN SALES, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressMadison, NJ 92612

Party NameActavis, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Party NameActavis, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events


Event DateEvent Description
Monday, April 26, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 26, 2021ABANDONMENT - NO USE STATEMENT FILED
Saturday, September 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 11, 2020EXTENSION 5 GRANTED
Wednesday, September 9, 2020EXTENSION 5 FILED
Wednesday, September 9, 2020TEAS EXTENSION RECEIVED
Tuesday, March 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 13, 2020EXTENSION 4 GRANTED
Friday, March 13, 2020EXTENSION 4 FILED
Friday, March 13, 2020TEAS EXTENSION RECEIVED
Wednesday, September 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 16, 2019EXTENSION 3 GRANTED
Monday, September 16, 2019EXTENSION 3 FILED
Monday, September 16, 2019TEAS EXTENSION RECEIVED
Tuesday, March 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 1, 2019EXTENSION 2 GRANTED
Friday, March 1, 2019EXTENSION 2 FILED
Friday, March 1, 2019TEAS EXTENSION RECEIVED
Saturday, September 29, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 28, 2018EXTENSION 1 GRANTED
Friday, September 7, 2018EXTENSION 1 FILED
Tuesday, September 18, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 7, 2018TEAS EXTENSION RECEIVED
Tuesday, March 20, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 23, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 23, 2018PUBLISHED FOR OPPOSITION
Wednesday, January 3, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, January 3, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 11, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 3, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, January 30, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 3, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, June 24, 2016REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, June 23, 2016ASSIGNED TO LIE
Tuesday, December 8, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, December 8, 2015LETTER OF SUSPENSION E-MAILED
Tuesday, December 8, 2015SUSPENSION LETTER WRITTEN
Thursday, December 3, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 2, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 2, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 9, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 9, 2015NON-FINAL ACTION E-MAILED
Tuesday, June 9, 2015NON-FINAL ACTION WRITTEN
Thursday, June 4, 2015ASSIGNED TO EXAMINER
Friday, April 10, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 4, 2015NEW APPLICATION ENTERED IN TRAM